Skip to main content
OpenTrials
Completed

NCT Number: NCT07331415

Evaluation of Lifestyle Education and Events Via Network Text Messages After Acute Coronary Syndrome

To evaluate the usefulness of telephone text messages (TTM) in the control of risk factors and in the reduction of events in the first year after an ACS (acute coronary syndrome).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Coronary Syndrome Cardiovascular Diseases Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Universitario de Cabueñes

Cabueñes, Spain

About this study

To evaluate the usefulness of telephone text messages (TTM) in the control of risk factors and in the reduction of events in the first year after an ACS (acute coronary syndrome).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients discharged with ACS and without ST elevation.
  • Informed consent signed.

Exclusion criteria

  • Refusal to participate in the study.

Treatment and study plan

Text messaging and Usual Care

Other

The patient received a monthly telephone text messages (TTM) for 12 months with the recommendations of the Spanish Society of Cardiology regarding secondary prevention and followed the usual review protocol in a specific ischemic heart disease consultation at 3 and 12 months after discharge.

Usual Care

Behavioral

The patient received followed the usual review protocol in a specific ischemic heart disease consultation at 3 and 12 months after discharge.

Primary outcomes

  1. Composite of cardiac death, myocardial infarction, stroke or new revascularization

    Time frame: 12 months

    Occurrence of Composite of cardiac death, myocardial infarction, stroke or new revascularization

Secondary outcomes

  1. Systolic blood pressure (SBP) mm Hg

    Time frame: 12 months

    Mean of SBP

  2. Diastolic blood pressure (DBP) (mm Hg)

    Time frame: 12 months

    Mean of DBP

  3. Change in Weight (kilograms)

    Time frame: 12 months

    Mean of Change in Weight

  4. Low Density Lipoproteins (LDL) cholesterol (mg/dl)

    Time frame: 12 months

    Mean of LDL

  5. High (HDL) cholesterol (mg/dl)

    Time frame: 12 months

    Mean of LDL

  6. Triglycerides (mg/dl)

    Time frame: 12 months

    Mean of Triglycerides

  7. Glycosylated hemoglobin (%)

    Time frame: 12 months

    Mean of Glycosylated hemoglobin

  8. Active smoking

    Time frame: 12 months

    Percentage of Active smoking

  9. Exercise per week (hours)

    Time frame: 12 months

    Mean of Exercise per week

  10. Total Death

    Time frame: 12 months

    Occurrence of All Death

  11. Cardiac Death

    Time frame: 12 months

    Occurrence of Cardiovascular Death

  12. Myocardial Infarction

    Time frame: 12 months

    Occurrence of Myocardial Infarction

  13. Stroke

    Time frame: 12 months

    Occurrence of Stroke

  14. New revascularization

    Time frame: 12 month

    Occurrence of New revascularization

Sponsors and collaborators

Lead sponsor

Fundación EPIC

Other

Registry information

Official study title

Evaluation of Lifestyle Education and Events Via Network Text Messages After Acute Coronary Syndrome (Elena Trial)

Acronym: Elena

Important dates

Study start
2019
Primary completion
2023
Study completion
2023
First posted
Jan 9, 2026
Registry last updated
Jan 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.